U.S. Markets closed

EDAP TMS S.A. (EDAP)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.77-0.03 (-1.07%)
At close: 4:00PM EDT
People also watch
DYNTDRADESMCIRIXPSDV
  • Shaping up to be the protocol for Stage 1 & 2 prostate cancer with $1000 per procedure for peripherals, not counting sale or lease of machines, with 1.2 million prostate cancers per year, they could capture a significant percentage. Good times coming.
  • In my opinion, EDAP is a fantastic investment. They are on the cusp of a breakout. They are profitable with PLENTY of cash (Over 22 million). Their sales are INCREASING, with C code for insurance reimbursement they are going to increase SIGNIFICANTLY. I'm happy with the products and the management. EDAP is one of the best run companies I've ever seen. Patience will be rewarded. I see EDAP's share price hitting double digits before year end. Good luck to all !
  • I only $2.90 the stock should be anywhere from 5 to $10 a share now
  • Spectacular failures. And the market id telling us loudly and clearly that hifu is worthless.
  • So now it's just as if that code approval never happened. Still at an abysmal level. You just can't get past incompetent, failed management and that's now clear to everyone. And the pathetic management shill just highlights that with his drivel and silly posting of eight approvals immediately after he posts his nonsense. Olcashowitz should be so embarrassed that that kind of junk is posted in support of his truly failed tenure.
  • The actions of management strongly support my thesis since it is obvious that they don't believe the company has a long-range future. They have twice gone to the well with placements for cash they didn't really need diluting the stock by 100% in the process. They don't own any stock so that was fine with them. But now they can carry on drawing undeserved salaries and losing a couple of million a year for a dozen more years.
  • Reimbursement, WOW THAT WAS QUICK...

    Great news, and excited it starts on July 1st.
  • Can you please provide me the exact scope of the reimbursement. Will this be the USA and for all medical insurance companies?
  • IMPORTANT QUOTE FROM CONFERENCE CALL LAST WEEK "Private or commercial insurers may also recognize and accept C-Code."

    "I would like to further clarify what a C-CODE as the reimbursement process is complicated and might generate some confusion because our unique temporary pricing code that CMS initially established for hospitals to report from services and their the hospital outpatient prospective payment system or PPS equals are used on Medicare or PPS but may also be recognized on claims from other providers or by other payment systems. In CMS, originally established then C-Codes have evolved and they also now target unique hospital services that may be provided by OPPs providers or providers paid under the other payment system. Private or commercial insurers may also recognize and accept C-Code. The C-Code is likely to cover only the HIFU facility payment for HIFU ablation, the hospital may receive additional payment for other services and the physicians and the physiology (phon) fees will be billed and paid separately. We should have feedback and a decision from CMS during June for an effective date of this decision by July 1, 2017." Transcript courtesy of Seeking Alpha.
  • I'm in and can't wait to see the rest of the year ...
  • Management has certainly been completely incompetent, but let's be fair here. At this point the technology and this company are no longer obscure. Thus the only rational conclusion would be that most knowledgeable players have concluded that hifu has no real future.
  • I have $15,500 shares for sale for $20 a share first come first serve
  • Should be over 4 by now. Instead no trades for half an hour because of those 7100 shares for sale at 3 that we can't get by.
  • It should be a done deal for positive decision. There is no reason for insurance company pay more for radiation and surgery.
  • Johns Hopkins researchers figure out how to deliver drugs to brain using ultrasound
    In study, sound wave pulses trigger release of drugs encased in nanoparticles 'cages'
    ByShawna Williams / Published Jan 24
    Biomedical engineers at Johns Hopkins report they have worked out a noninvasive way to release and deliver concentrated amounts of a drug to the brain of rats in a temporary, localized manner using ultrasound. The method "cages" a drug inside tiny, biodegradable "nanoparticles," then activates its release through precisely targeted sound waves, such as those used to create images of internal organs.

    Scientific illustration depicts a nanoparticle with a non-permeable barrier undergoing ultrasound pulses, making the barrier more permeable and releasing small particles of the drug
    Image caption: When drug-laden nanoparticles (left) absorb energy from ultrasound waves, their liquid center (green) turns to gas and expands the particles (right), loosening their exterior and releasing the drug (blue)
    IMAGE CREDIT: RAAG AIRAN
    Because most psychoactive drugs could be delivered this way, as well as many other types of drugs, the researchers say their method has the potential to advance many therapies and research studies inside and outside the brain.

    The researchers say that their method should minimize a drug's side effects because the drug's release is concentrated in a small area of the body, so the total amount of drug administered can be much lower. And because the individual components of the technology—including the use of the specific biomaterials, ultrasound, and FDA-approved drugs—have already been tested in people and found to be safe, the researchers believe their method could be brought into clinical use more quickly than usual. They hope to start the regulatory approval process within the next year or two.

    "If further testing of our combination method works in humans, it will not only give us a way to direct medications to specific areas of the brain, but will also let us learn a lot more about the function of each brain area," said Jordan Green, associate professor of biomedical engineering, who is also a member of JHU's Kimmel Cancer Center and Institute for NanoBioTechnology.

    Details of the research were published Monday in the journal Nano Letters.

    In their experiments, Green's group designed nanoparticles with an outer expandable "cage" made of a biodegradable plastic. The center of the cage was filled with the liquid perfluoropentane. When the sound waves of ultrasound—delivered noninvasively across the rats' scalp and skull—strike perfluoropentane in the center of the nanoparticles, the liquid transforms to a gas, expanding the surrounding cage and letting the drug escape.

    The new research, Green says, was designed to further advance means of getting drugs safely to the brain, a delicate and challenging organ to treat. To protect itself from infectious agents—and from swelling that can be caused by the immune system, for example—the brain is surrounded by a molecular fence, called the blood-brain barrier, which lines the surface of every blood vessel feeding the brain. Only very small drug molecules that dissolve in oil can get through the fence, along with gases. Because of this, most drugs developed for treating brain disorders fit those criteria but are dispersed to all parts of the brain—and the rest of the body, where they may be unneeded and unwanted.

    "When working with a patient who has post-traumatic stress disorder, for example, it would be nice to quiet down the overactive part of the brain—for instance, the amygdala—during talk therapy sessions," says Raag Airan, assistant professor of radiology at Stanford University Medical Center and co-author of the paper. "Current technologies can at best quiet down half of the brain at a time, so they are too nonspecific to be useful in this setting."
  • Seems very similar to what Celsion is already doing with "heat activated" liposomes for liver cancer. However, they are actually using a heat element rather than ultrasound. I believe they may have used ultrasound in some small trials.
  • The multi-id employee shill is just such a joke now as is the management of this sorry mess. Olcashowitz should have been bounced long, long ago before he was able to reward Wainwright, Northland, Sabby, Greenleaf and who knows how many others while stiffing his shareholders and even mocking them by not even owning any significant amount of stock.
  • The multi-id employee shill is just such a joke now as is the management of this sorry mess. Olcashowitz should have been bounced long, long ago before he was able to reward Wainwright, Northland, Sabby, Greenleaf and who knows how many others while stiffing his shareholders and even mocking them by not even owning any significant amount of stock.
  • Hc wainwright rated - buy ... we shall see :)
  • Relatively new HIFU video on Youtube
    https://www.youtube.com/watch?v=shGqoKBPQT0

    HIFU FOCAL ONE TREATMENT
    http: Specialiste-en-urologie.fr INTRO : Concept We are going to present to you the use of 3D Keolis cartography during Hifu focal one treatment procedure. T...
    www.youtube.com